Rapt Therapeutics (NASDAQ: RAPT) recently received a number of ratings updates from brokerages and research firms: 11/7/2025 – Rapt Therapeutics had its price target lowered by analysts at Barclays PLC from $58.00 to $56.00. They now have an “overweight” rating on the stock. 11/3/2025 – Rapt Therapeutics was given a new $72.00 price target on […]

Several analysts have recently updated their ratings and price targets for Ovintiv (NYSE: OVV): 11/6/2025 – Ovintiv had its “outperform” rating reaffirmed by analysts at Evercore ISI. They now have a $47.00 price target on the stock. 11/5/2025 – Ovintiv had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 10/22/2025 – Ovintiv had […]

Nexa Resources (NYSE: NEXA) has recently received a number of price target changes and ratings updates: 11/3/2025 – Nexa Resources had its price target raised by analysts at Scotiabank from $6.00 to $7.00. They now have a “sector perform” rating on the stock. 11/1/2025 – Nexa Resources was upgraded by analysts at Wall Street Zen […]

A number of research firms have changed their ratings and price targets for CompoSecure (NASDAQ: CMPO): 11/4/2025 – CompoSecure had its “buy” rating reaffirmed by analysts at Cowen Inc. 11/4/2025 – CompoSecure had its price target raised by analysts at Lake Street Capital from $21.00 to $25.00. They now have a “buy” rating on the […]